PODOM 30ML D.SYR India - English - Central Drugs Standard Control Organization

podom 30ml d.syr

epitome - cefpodoxime - d.syr - 50mg/5ml - 30ml

PODOM 50/50 DT TAB India - English - Central Drugs Standard Control Organization

podom 50/50 dt tab

epitome - cefpodoxime - dt tab - 100/200;mg - 50/50

PODOM-KID 100 DT TAB India - English - Central Drugs Standard Control Organization

podom-kid 100 dt tab

epitome - cefpodoxime - dt tab - 50mg - 100

RABETOME 100 DM TAB India - English - Central Drugs Standard Control Organization

rabetome 100 dm tab

epitome - rabeprazole,domperidone - dm tab - 20,10;mg - 100

RABETOME DSR 100 TAB India - English - Central Drugs Standard Control Organization

rabetome dsr 100 tab

epitome - rabeprazole,domperidone - tab - 20,10(sr);mg - 100

VELETRI POWDER FOR SOLUTION FOR INFUSION 0.5MGVIAL Singapore - English - HSA (Health Sciences Authority)

veletri powder for solution for infusion 0.5mgvial

johnson & johnson international (singapore) pte ltd - epoprostenol sodium 0.531mg eqv epoprostenol - injection, powder, for solution - epoprostenol sodium 0.531mg eqv epoprostenol 0.5mg

VELETRI POWDER FOR SOLUTION FOR INFUSION 1.5MGVIAL Singapore - English - HSA (Health Sciences Authority)

veletri powder for solution for infusion 1.5mgvial

johnson & johnson international (singapore) pte ltd - epoprostenol sodium 1.593mg eqv epoprostenol - injection, powder, for solution - epoprostenol sodium 1.593mg eqv epoprostenol 1.5mg

Veletri New Zealand - English - Medsafe (Medicines Safety Authority)

veletri

janssen-cilag (new zealand) ltd - epoprostenol sodium 1.593mg equivalent to epoprostenol 1.5 mg - powder for injection - 1.5 mg - active: epoprostenol sodium 1.593mg equivalent to epoprostenol 1.5 mg excipient: arginine sodium hydroxide sucrose - veletri is indicated for the long-term treatment, via continuous intravenous infusion, in who functional class iii and iv patients with: · idiopathic pulmonary arterial hypertension · familial pulmonary arterial hypertension · pulmonary arterial hypertension asscociated with the scleroderma spectrum of diseases.

Veletri New Zealand - English - Medsafe (Medicines Safety Authority)

veletri

janssen-cilag (new zealand) ltd - epoprostenol sodium 531ug equivalent to epoprostenol 500 mcg - powder for injection - 500 mcg - active: epoprostenol sodium 531ug equivalent to epoprostenol 500 mcg excipient: arginine sodium hydroxide sucrose - veletri is indicated for the long-term treatment, via continuous intravenous infusion, in who functional class iii and iv patients with: · idiopathic pulmonary arterial hypertension · familial pulmonary arterial hypertension · pulmonary arterial hypertension associated with the scleroderma spectrum of diseases.

VELETRI epoprostenol (as sodium) 500 microgram powder for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

veletri epoprostenol (as sodium) 500 microgram powder for injection vial

janssen-cilag pty ltd - epoprostenol sodium, quantity: 531 microgram (equivalent: epoprostenol, qty 500 microgram) - powder - excipient ingredients: arginine; sodium hydroxide; sucrose - veletri is indicated for the long-term treatment, via continuous intravenous infusion, in who functional class iii or class iv patients with:,? idiopathic pulmonary arterial hypertension,? familial pulmonary arterial hypertension,? pulmonary arterial hypertension associated with the scleroderma spectrum of diseases